missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human IL-6 Protein
A New rh IL-6 is Available! The new protein has ∼2 fold better activity and is HEK293 expressed!
547.00 CHF - 4670.00 CHF
Spezifikation
| Zugriffsnummer | Q75MH2 |
|---|---|
| Zur Verwendung mit (Anwendung) | Bioactivity |
| Zusammensetzung | Lyophilized from a 0.2 μm filtered solution in PBS and NaCl. |
| Gen-ID (Entrez) | 3569 |
| Molekulargewicht | M.W. theroretical: 20.9 kDa |
| Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
|---|---|---|---|---|---|---|---|---|---|
| Produktcode | Marke | Menge | Preis | Menge & Verfügbarkeit | |||||
|
18776806
|
R&D Systems™
206-IL-025/CF |
25 μg |
547.00 CHF
25 Mikrogramm |
Verfügbar ab: 12-11-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
|
18354837
|
R&D Systems™
206-IL-001MG/CF |
1 mg |
4670.00 CHF
1 Milligramm |
Verfügbar ab: 07-11-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
|
18128360
|
R&D Systems™
206-IL-050/CF |
50 μg |
1105.00 CHF
50 Mikrogramm |
Verfügbar ab: 07-11-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
|
18748906
|
R&D Systems™
206-IL-200/CF |
200 μg |
1505.00 CHF
200 Mikrogramm |
Verfügbar ab: 12-11-2024
Loggen Sie sich ein, um den Lagerbestand zu sehen |
|||||
Beschreibung
Measured in a cell proliferation assay using T1165.85.2.1 mouse plasmacytoma cells. Nordan, R.P. et al. (1987) J. Immunol. 139:813. The ED50 for this effect is 0.2-0.8 ng/mL.Spezifikation
| Q75MH2 | |
| Lyophilized from a 0.2 μm filtered solution in PBS and NaCl. | |
| M.W. theroretical: 20.9 kDa | |
| E. coli-derived human IL-6 protein Pro29-Met212 | |
| <0.10 EU / 1 μg of the protein by the LAL method. | |
| IL6 | |
| Recombinant | |
| IL-6 |
| Bioactivity | |
| 3569 | |
| IL-6 | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
| B-cell differentiation factor, B-cell stimulatory factor 2, BSF2, BSF-2, CDF, CTL differentiation factor, HSF, hybridoma growth factor, IFNB2, IFN-beta-2, IL6, IL-6, Interferon beta-2, interleukin 6 (interferon, beta 2), interleukin BSF-2, interleukin-6, MGI-2A | |
| Unconjugated | |
| >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |